Stem Cell Reviews And Reports SCIE

國(guó)際簡(jiǎn)稱：STEM CELL REV 參考譯名：干細(xì)胞評(píng)論和報(bào)告

主要研究方向：CELL & TISSUE ENGINEERING-CELL BIOLOGY 非預(yù)警期刊審稿周期：

《干細(xì)胞評(píng)論和報(bào)告》(Stem Cell Reviews And Reports)是一本由Springer US出版的以CELL & TISSUE ENGINEERING-CELL BIOLOGY為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
169 年發(fā)文量
4.5 IF影響因子
未開(kāi)放 是否OA
61 H-index
2005 創(chuàng)刊年份
8 issues per year 出版周期
English 出版語(yǔ)言

The purpose of Stem Cell Reviews and Reports is to cover contemporary and emerging areas in stem cell research and regenerative medicine. The journal will consider for publication:

i) solicited or unsolicited reviews of topical areas of stem cell biology that highlight, critique and synthesize recent important findings in the field.

ii) full length and short reports presenting original experimental work.

iii) translational stem cell studies describing results of clinical trials using stem cells as therapeutics.

iv) papers focused on diseases of stem cells.

v) hypothesis and commentary articles as opinion-based pieces in which authors can propose a new theory, interpretation of a controversial area in stem cell biology, or a stem cell biology question or paradigm. These articles contain more speculation than reviews, but they should be based on solid rationale.

vi) protocols as peer-reviewed procedures that provide step-by-step descriptions, outlined in sufficient detail, so that both experts and novices can apply them to their own research.

vii) letters to the editor and correspondence.

In order to facilitate this exchange of scientific information and exciting novel ideas, the journal has created five thematic sections, focusing on:

i) the role of adult stem cells in tissue regeneration;

ii) progress in research on induced pluripotent stem cells, embryonic stem cells and mechanism governing embryogenesis and tissue development;

iii) the role of microenvironment and extracellular microvesicles in directing the fate of stem cells;

iv) mechanisms of stem cell trafficking, stem cell mobilization and homing with special emphasis on hematopoiesis;

v) the role of stem cells in aging processes and cancerogenesis.

[ 查看全部 ]

投稿咨詢加急咨詢

Stem Cell Reviews And Reports期刊信息

ISSN：1550-8943
出版語(yǔ)言：English
是否OA：未開(kāi)放
E-ISSN：2629-3277
出版地區(qū)：UNITED STATES
是否預(yù)警：否
出版商：Springer US
出版周期：8 issues per year
創(chuàng)刊時(shí)間：2005
開(kāi)源占比：0.2758
Gold OA文章占比：32.49%
OA被引用占比：0.2488...
出版國(guó)人文章占比：0.12
出版撤稿占比：0
研究類文章占比：94.67%

Stem Cell Reviews And Reports CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

9.3

1.19

0.843

學(xué)科類別	分區(qū)	排名	百分位
大類：Biochemistry, Genetics and Molecular Biology 小類：Cell Biology	Q2	72 / 285	74%
大類：Biochemistry, Genetics and Molecular Biology 小類：Cancer Research	Q2	59 / 230	74%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書(shū)籍章節(jié)和數(shù)據(jù)論文。

Stem Cell Reviews And Reports中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 CELL BIOLOGY 細(xì)胞生物學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū) 3區(qū) 3區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 CELL BIOLOGY 細(xì)胞生物學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū) 3區(qū) 3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 CELL BIOLOGY 細(xì)胞生物學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū) 3區(qū) 3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 CELL BIOLOGY 細(xì)胞生物學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū) 3區(qū) 2區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 CELL BIOLOGY 細(xì)胞生物學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū) 3區(qū) 3區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	CELL BIOLOGY 細(xì)胞生物學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) CELL & TISSUE ENGINEERING 細(xì)胞與組織工程	2區(qū) 2區(qū) 3區(qū)

Stem Cell Reviews And Reports JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL & TISSUE ENGINEERING	SCIE	Q2	10 / 31	69.4%
學(xué)科：CELL BIOLOGY	SCIE	Q2	72 / 205	65.1%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	52 / 189	72.8%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL & TISSUE ENGINEERING	SCIE	Q2	10 / 31	69.35%
學(xué)科：CELL BIOLOGY	SCIE	Q2	63 / 205	69.51%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	49 / 189	74.34%

Stem Cell Reviews And Reports歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Stem Cell Reviews And Reports中國(guó)學(xué)者發(fā)文選摘

1、Combining Bone Collagen Matrix with hUC-MSCs for Application to Alveolar Process Cleft in a Rabbit Model
Author: Sun, Xue-Cheng; Wang, Hu; Zhang, Dan; Li, Jian-Hui; Yin, Li-Qiang; Yan, Yu-Fang; Ma, Xu; Xia, Hong-Fei

Journal: STEM CELL REVIEWS AND REPORTS. 2023; Vol. 19, Issue 1, pp. 133-154. DOI: 10.1007/s12015-021-10221-y
2、Mesenchymal Stem Cell-Derived Extracellular Vesicles: The Novel Therapeutic Option for Regenerative Dentistry
Author: Kong, Haiying; Liu, Peiqi; Li, Hongwen; Zeng, Xiantao; Xu, Peiwu; Yao, Xinhui; Liu, Senqing; Cheng, Chak Kwong; Xu, Jian

Journal: STEM CELL REVIEWS AND REPORTS. 2023; Vol. 19, Issue 1, pp. 46-58. DOI: 10.1007/s12015-022-10342-y
3、Exosomal microRNA-4535 of Melanoma Stem Cells Promotes Metastasis by Inhibiting Autophagy Pathway
Author: Liu, Doudou; Li, Xiaoshuang; Zeng, Bin; Zhao, Qiting; Chen, Hao; Zhang, Yuhan; Chen, Yuting; Wang, Jianyu; Xing, H. Rosie

Journal: STEM CELL REVIEWS AND REPORTS. 2023; Vol. 19, Issue 1, pp. 155-169. DOI: 10.1007/s12015-022-10358-4
4、LncRNA RAD51-AS1 Regulates Human Bone Marrow Mesenchymal Stem Cells via Interaction with YBX1 to Ameliorate Osteoporosis
Author: Li, Beichen; Wang, Jing; Xu, Fangrong; Wang, Qinjue; Liu, Quan; Wang, Guantong; Miao, Dengshun; Sun, Qiang

Journal: STEM CELL REVIEWS AND REPORTS. 2023; Vol. 19, Issue 1, pp. 170-187. DOI: 10.1007/s12015-022-10408-x
5、Osteomodulin protects dental pulp stem cells from cisplatin-induced apoptosis in vitro
Author: Dong, Ting; Lin, Wen-zhen; Zhu, Xiao-han; Yuan, Ke-yong; Hou, Li-li; Huang, Zheng-wei

Journal: STEM CELL REVIEWS AND REPORTS. 2023; Vol. 19, Issue 1, pp. 188-200. DOI: 10.1007/s12015-022-10399-9
6、Defect-adaptive Stem-cell-microcarrier Construct Promotes Tissue Repair in Rabbits with Knee Cartilage Defects
Author: Zhao, Zhidong; Wang, Yuxing; Yin, Bofeng; Li, Xiaotong; Hao, Ruicong; Li, Zhiling; Li, Peilin; Han, Mengyue; Ding, Li; Li, Zhongli; Zhu, Heng

Journal: STEM CELL REVIEWS AND REPORTS. 2023; Vol. 19, Issue 1, pp. 201-212. DOI: 10.1007/s12015-022-10421-0
7、Isolation of Swine Bone Marrow Lin-/CD45-/CD133+Cells and Cardio-protective Effects of its Exosomes
Author: Li, Hongxiao; Gu, Jianjun; Sun, Xiaolin; Zuo, Qisheng; Li, Bichun; Gu, Xiang

Journal: STEM CELL REVIEWS AND REPORTS. 2023; Vol. 19, Issue 1, pp. 213-229. DOI: 10.1007/s12015-022-10432-x
8、Nuclear Tubulin Enhances CXCR4 Transcription and Promotes Chemotaxis Through TCF12 Transcription Factor in human Hematopoietic Stem Cells
Author: Geng, Nanxi; Yu, Ziqin; Zeng, Xingchao; Xu, Danhua; Gao, Hai; Yang, Min; Huang, Xinxin

Journal: STEM CELL REVIEWS AND REPORTS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12015-023-10543-z